Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYJAAD international

CDKN2A c.146T>C (I49T) in Mexican-ancestry individuals: Findings from melanoma and population cohorts

  • Brooke Bartley1
  • Ariel B. Brown1
  • Amr Salem2
  • Isabella Ribaudo2
  • Sophia N. Wix1
  • Marelize Snyman1
  • Jacqueline A. Mersch3
  • Amber P. Gemmell3
  • Rebecca Vasquez1
  • Kelly C. Nelson4
  • Joshua Arbesman2
  • Jennifer G. Gill1
4 affiliations
  1. 1Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas
  2. 2Department of Dermatology, Medical Specialty Institute, Cleveland Clinic, Cleveland, Ohio
  3. 3Cancer Genetics Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas
  4. 4Department of Dermatology, MD Anderson Medical Center, Houston, Texas
Read full textPDFCite

Related

  1. Association of EGLN1 and EGLN3 genetic variants with COVID-19 severity in a Mexican population
    Laura E. Martínez-Gómez, Eliurde Valle-Rivera, Carlos Martinez-Armenta +20
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
  2. Use of COVID-19 Detection Tests in the Mexican Population from 2020-2022: Frequency and Distribution.
    Irene Parada-Toro, Hortensia Reyes-Morales, Juan Espiniza-Montero +2
    Revista brasileira de enfermagemPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  3. Multi-modal data Integration for Metastatic Risk Prediction of AJCC Stage I/II Melanomas: Results from the Population-based Dutch Early-stage Melanoma Study (D-ESMEL)
    J. Ouwerkerk, T. Kerkour, C. Zhou +5
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  4. 454 Second primary hematologic malignancies in melanoma survivors before and after the introduction of immune checkpoint inhibitors: a population-based SEER analysis
    Jeffrey Afrifa-Yamoah, Damilola Ologbe, Duresha Malik +5
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ
  5. Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial.
    Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina +11
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{bartley2026cdkn2a,
  title = {{CDKN2A c.146T>C (I49T) in Mexican-ancestry individuals: Findings from melanoma and population cohorts}},
  author = {Brooke Bartley and Ariel B. Brown and Amr Salem and Isabella Ribaudo and Sophia N. Wix and Marelize Snyman and Jacqueline A. Mersch and Amber P. Gemmell and Rebecca Vasquez and Kelly C. Nelson and Joshua Arbesman and Jennifer G. Gill},
  journal = {JAAD international},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13676904},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - CDKN2A c.146T>C (I49T) in Mexican-ancestry individuals: Findings from melanoma and population cohorts
AU  - Brooke Bartley
AU  - Ariel B. Brown
AU  - Amr Salem
AU  - Isabella Ribaudo
AU  - Sophia N. Wix
AU  - Marelize Snyman
AU  - Jacqueline A. Mersch
AU  - Amber P. Gemmell
AU  - Rebecca Vasquez
AU  - Kelly C. Nelson
AU  - Joshua Arbesman
AU  - Jennifer G. Gill
PY  - 2026
DA  - 2026/09/15
JO  - JAAD international
UR  - https://europepmc.org/article/PMC/PMC13676904
SN  - 2666-3287
ER  -